These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 15506717)

  • 1. [Should we support large-scale screening for genetic haemochromatosis in France?].
    Deugnier Y; Le Gall JY
    Bull Acad Natl Med; 2004; 188(2):265-72; discussion 272-3. PubMed ID: 15506717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening blood donors for hereditary hemochromatosis: decision analysis model comparing genotyping to phenotyping.
    Adams PC; Valberg LS
    Am J Gastroenterol; 1999 Jun; 94(6):1593-600. PubMed ID: 10364030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors affecting the uptake of screening: a randomised controlled non-inferiority trial comparing a genotypic and a phenotypic strategy for screening for haemochromatosis.
    Patch C; Roderick P; Rosenberg W
    J Hepatol; 2005 Jul; 43(1):149-55. PubMed ID: 15876471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hereditary hemochromatosis screening: effect of mutation penetrance and prevalence on cost-effectiveness of testing algorithms.
    Gagné G; Reinharz D; Laflamme N; Adams PC; Rousseau F
    Clin Genet; 2007 Jan; 71(1):46-58. PubMed ID: 17204047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for hemochromatosis: phenotype versus genotype.
    Edwards CQ; Griffen LM; Ajioka RS; Kushner JP
    Semin Hematol; 1998 Jan; 35(1):72-6. PubMed ID: 9460810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cost-effectiveness of screening for hereditary hemochromatosis in Germany: a remodeling study.
    Rogowski WH
    Med Decis Making; 2009; 29(2):224-38. PubMed ID: 19182214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic screening for HFE hemochromatosis in 6,020 Danish men: penetrance of C282Y, H63D, and S65C variants.
    Pedersen P; Milman N
    Ann Hematol; 2009 Aug; 88(8):775-84. PubMed ID: 19159930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic discrimination and screening for hemochromatosis.
    Alper JS; Geller LN; Barash CI; Billings PR; Laden V; Natowicz MR
    J Public Health Policy; 1994; 15(3):345-58. PubMed ID: 7983195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The penetrance of hereditary hemochromatosis.
    Waalen J; Nordestgaard BG; Beutler E
    Best Pract Res Clin Haematol; 2005 Jun; 18(2):203-20. PubMed ID: 15737885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Searching for hereditary hemochromatosis.
    Laudicina RJ
    Clin Lab Sci; 2006; 19(3):174-83. PubMed ID: 16910235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population screening for hemochromatosis--are we finding people with a disease or a biochemical curiosity?
    Adams PC
    Semin Gastrointest Dis; 2002 Apr; 13(2):89-94. PubMed ID: 12064864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fear of harm, a possible phenotype of pediatric bipolar disorder: a dimensional approach to diagnosis for genotyping psychiatric syndromes.
    Papolos D; Mattis S; Golshan S; Molay F
    J Affect Disord; 2009 Nov; 118(1-3):28-38. PubMed ID: 19631388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic screening for iron overload: No evidence of discrimination at 1 year.
    Hall MA; Barton JC; Adams PC; McLaren CE; Reiss JA; Castro O; Ruggiero A; Acton RT; Power TE; Bent TC
    J Fam Pract; 2007 Oct; 56(10):829-34. PubMed ID: 17908514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persons with screening-detected haemochromatosis: as healthy as the general population?
    Asberg A; Hveem K; Krüger O; Bjerve KS
    Scand J Gastroenterol; 2002 Jun; 37(6):719-24. PubMed ID: 12126253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haemochromatosis and family testing. What should a GP do?
    Newstead J; Delatycki M; Aitken MA
    Aust Fam Physician; 2002 Jun; 31(6):533-7. PubMed ID: 12154600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Educational outcomes of a workplace screening program for genetic susceptibility to hemochromatosis.
    Nisselle AE; Collins VR; Gason AA; Flouris A; Delatycki MB; Allen KJ; Aitken MA; Metcalfe SA
    Clin Genet; 2006 Feb; 69(2):163-70. PubMed ID: 16433697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An analysis of the proposal for population based screening for hereditary hemochromatosis in Massachusetts.
    LeGraw JM
    J Biolaw Bus; 2001; 4(4):51-8. PubMed ID: 12751496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The prioritisation of genetic screening with primary haemochromatosis as an example].
    de Craen AJ; van Aken MO; Westendorp RG
    Ned Tijdschr Geneeskd; 2003 Jul; 147(30):1442-5. PubMed ID: 12908344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for hemochromatosis in asymptomatic subjects with or without a family history.
    Powell LW; Dixon JL; Ramm GA; Purdie DM; Lincoln DJ; Anderson GJ; Subramaniam VN; Hewett DG; Searle JW; Fletcher LM; Crawford DH; Rodgers H; Allen KJ; Cavanaugh JA; Bassett ML
    Arch Intern Med; 2006 Feb; 166(3):294-301. PubMed ID: 16476869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.